Using aminophylline to improve ureteral access for kidney stones
Official title: Efficacy of Intra-Ureteric Aminophylline Installation After Failed Stone Accessibility by Semi-rigid Ureteroscopy. Prospective Trial
Run by Al-Azhar University · NCT06728943 · Data updated 2026-11-12
This study is testing if using aminophylline can help people who have had trouble with kidney stone removal through a specific procedure to make it easier and safer.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Al-Azhar University Academic / other |
| Locations | 1 site (Cairo) |
| Status | Recruiting |
| Started | December 1, 2024 |
| Main results expected | December 1, 2028 |
| Study ends | December 1, 2028 |
| Registry record updated | December 11, 2024 |
| Trial ID | NCT06728943 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients who have experienced failed stone accessibility by semi-rigid ureteroscopy.
✕Probably not a fit
Patients who are children, have contraindications to aminophylline, or have active urinary tract infections will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of local intraureteric aminophylline instillation in patients who have previously experienced failed access to ureteric stones via semi-rigid ureteroscopy. The approach aims to facilitate stone removal without the need for balloon dilation, potentially reducing complications associated with ureteroscopy. By relaxing smooth muscle and alleviating inflammation, aminophylline may enhance the success rate of ureteroscopic procedures. The study will include patients who meet specific criteria and will be conducted at Al-Azhar University in Cairo.
Why it matters
Potential benefit: If successful, this approach could improve the success rate of ureteroscopic procedures for patients with ureteric stones.
How similar studies have gone: While the use of aminophylline in this context is novel, similar studies have explored its effects in other urological applications, indicating potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * The study will include patients with failed stone accessibility by semi-rigid ureteroscopy. Exclusion Criteria: * Child age group * Pre stented patients * Contraindications to aminophylline (hypersensitivity to drug components, pregnancy or lactation ,…) * Contraindications to ureteroscopy (active urinary tract infection - Contraindications to general or spinal anesthesia - Uncorrected bleeding disorders)
Where it's running
-
Al-Azhar university, faculty of medicine, the urology department
Cairo, Egypt Recruiting
Study contacts
- Study coordinator: Mohamed Fawzy Mohamed Fawzy Salman, MD
- Email: prof_mohamed_fawzy@yahoo.com
- Phone: +201111788996
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tamsulosin 0.4 mg with Tadalafil 5 mg versus 2.5 mg to reduce symptoms from ureteral stents
This will test whether adding Tadalafil at 5 mg or 2.5 mg to Tamsulosin 0.4 mg better reduces stent-related symptoms for adults with a double-J ureteral stent after stone removal.
-
Flexible versus semi-rigid ureteroscopy for upper ureteric stones under 2 cm
This will test whether flexible or semi-rigid ureteroscopy works better for adults with upper ureteric stones smaller than 2 cm.
-
Comparing stent placement versus omission after kidney stone treatment
This study is testing whether putting in a stent after kidney stone treatment helps patients feel better and need fewer extra doctor visits compared to not using a stent at all.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.